Mind Medicine Inc
(NAS:MNMD)
$
7.08
-0.06 (-0.84%)
Market Cap: 508.86 Mil
Enterprise Value: 270.71 Mil
PE Ratio: 0
PB Ratio: 2.57
GF Score: 41/100 - Q1 2024 Mind Medicine (MindMed) Inc Earnings Call TranscriptMay 08, 2024$9.61 (+0.63%)Earnings
- Q4 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptFeb 28, 2024$5.35 (-3.78%)Earnings
- Mind Medicine (MindMed) Inc to Host Conference Call TranscriptDec 14, 2023
- Q3 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptNov 02, 2023$2.7 (+8.43%)Earnings
- Mind Medicine (MindMed) Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 28, 2023
- Q2 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptAug 03, 2023$4.71 (+2.61%)Earnings
- Mind Medicine (MindMed) Inc at H.C. Wainwright Neuropsychiatry Virtual Conference TranscriptJun 26, 2023
- Mind Medicine (MindMed) Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Mind Medicine (MindMed) Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Q1 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptMay 04, 2023$3.62 (-1.90%)Earnings
- Mind Medicine (MindMed) Inc at ROTH Conference TranscriptMar 13, 2023
- Mind Medicine (MindMed) Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Q4 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptMar 09, 2023$3.18 (-4.79%)Earnings
- Mind Medicine (MindMed) Inc at Cowen Health Care Conference TranscriptMar 08, 2023
- Mind Medicine (MindMed) Inc at Jefferies London Healthcare Conference TranscriptNov 16, 2022
- Q3 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptNov 10, 2022$2.6 (+7.88%)Earnings
- Q2 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptAug 11, 2022$9.75 (-0.21%)Earnings
- Mind Medicine (MindMed) Inc at Canaccord Genuity Growth Conference TranscriptAug 10, 2022
- Mind Medicine (MindMed) Inc at Jefferies Healthcare Conference TranscriptJun 10, 2022
- Q1 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptMay 16, 2022$12.01 (+2.64%)Earnings
- Q4 2021 Mind Medicine (MindMed) Inc Earnings Call TranscriptMar 28, 2022$17.4 (-1.69%)Earnings
- Q2 2021 Mind Medicine (MindMed) Inc Earnings Call TranscriptAug 16, 2021Earnings
Mind Medicine (MindMed) Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 17, 2023 / 08:35PM GMT
Release Date Price:
$3.15
(+3.96%)
Brian Abrahams
RBC Capital Markets - Analyst
Okay. Good afternoon, everyone. I'm Brian Abrahams, one of the senior biotech analysts here at RBC Capital Markets. Our last presenting company of the day is MindMed represented by their CEO, Rob Barrow. Rob, thanks so much for joining us.
Rob Barrow;MindMed;Inc.;CEO
Mind Medicine
()-
Thank you.
Brian Abrahams
RBC Capital Markets - Analyst
So let's start bigger picture. The psychedelic field has received a significant amount of interest lately. What drives your approach at MindMed and where do you see yourself as being most differentiated? And I'm thinking with respect to your asset itself, the indication, and indications you're going to be looking at, and your administration of such?
Questions & Answers
Rob Barrow;MindMed;Inc.;CEO
Mind Medicine
()-
Yeah, absolutely. I've had the good fortune of working with a number of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)